Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of L-arginine and N-acetylcysteine on nitric oxide production and blood pressure in diabetic and hypertensive patients
2004-004203-38Phase 3Completed
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Jan 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine and acetylcysteine in type 2 diabetes mellitus (T2DM) and hypertension (HTN), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Nitric oxide production and Blood pressure. Started Jan 2007; status: completed.
02
Drugs
arginineacetylcysteine
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on 2004-004203-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004203-38.